title: In reply.
authors.affiliation: Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia; Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle, Newcastle, New South Wale Australia.
authors.forename: Geoffrey Kennedy
authors.initials: GK
authors.lastname: Isbister
authors.affiliation: Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia.
authors.forename: Leonie
authors.initials: L
authors.lastname: Calver
authors.affiliation: Clinical Toxicology Research Group, University of Newcastle, Newcastle, New South Wales, Australia; Department of Clinical Toxicology and Pharmacology and the Emergency Department, Calvary Mater Newcastle, Newcastle, New South Wale, Australia.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Downes
authors.affiliation: Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; Emergency Department, Princess Alexandra Hospital, School of Medicine, Brisbane, Queensland, Australia; University of Queensland, Brisbane, Queensland, Australia.
authors.forename: Colin B
authors.initials: CB
authors.lastname: Page
mesh_terms: D016292:Procedural Sedation / Q000379:methods*; D003617:Dangerous Behavior; D004329:Droperidol / Q000627:therapeutic use*; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male
chemical_list: D006993:Hypnotics and Sedatives; D004329:Droperidol